PHARMA BASE
0441.943.282 · rovalta.com · 21/09/2026
PHARMA BASE
Overview
What does PHARMA BASE do?
PHARMA BASE is a Public limited company incorporated in 1990. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Genk. It employs on average 29,0 ETP workers (FTE).
3600 Genk · FlandreSee on map
Joint committees (2)
- 313
- 321
Trend over 13 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||
| Revenue | 75,2 M € | +25.1% | 60,2 M € | +15.4% | 52,1 M € | -7.2% | 56,2 M € | -1.0% | 56,8 M € | +22.4% | 46,4 M € | +41.4% | 32,8 M € | -21.9% | 42 M € | +55.3% | 27 M € | +27.1% | 21,3 M € | -4.3% | 22,2 M € | -18.9% | 27,4 M € | -12.0% | 31,2 M € |
| EBITDA | 480,1 k € | +37.4% | 349,3 k € | -17.4% | 422,7 k € | -46.4% | 787,9 k € | +30.9% | 601,8 k € | -47.2% | 1,1 M € | -51.0% | 2,3 M € | +231% | 701 k € | -37.3% | 1,1 M € | +137% | 472,1 k € | +163% | 179,8 k € | +108% | 86,4 k € | +109% | 41,4 k € |
| Operating result | 364,8 k € | +51.3% | 241,1 k € | -19.9% | 301,2 k € | -53.8% | 651,9 k € | +30.1% | 501,3 k € | -51.3% | 1 M € | -53.8% | 2,2 M € | +270% | 602,8 k € | -46.6% | 1,1 M € | +189% | 390,8 k € | +672% | 50,6 k € | +1204% | 3,9 k € | +114% | -28,1 k € |
| Net result | 178,9 k € | +328% | 41,8 k € | -71.6% | 147,3 k € | -69.7% | 485,5 k € | +48.4% | 327,2 k € | -51.5% | 674 k € | -28.0% | 935,5 k € | +240% | 275,4 k € | -62.2% | 728,4 k € | +3394% | 20,8 k € | +401% | -6,9 k € | +93.2% | -102 k € | -64.8% | -61,9 k € |
| Balance sheet | |||||||||||||||||||||||||
| Equity | 2,5 M € | +7.6% | 2,3 M € | +1.8% | 2,3 M € | -44.5% | 4,2 M € | +13.2% | 3,7 M € | +9.8% | 3,3 M € | +25.2% | 2,7 M € | +53.9% | 1,7 M € | +102% | 858 k € | +322% | 203,1 k € | +11.4% | 182,3 k € | -3.7% | 189,2 k € | -35.0% | 291,2 k € |
| Total assets | 21,1 M € | +10.4% | 19,1 M € | -3.9% | 19,9 M € | +13.3% | 17,5 M € | -4.5% | 18,3 M € | -7.4% | 19,8 M € | +35.9% | 14,6 M € | +34.9% | 10,8 M € | +10.2% | 9,8 M € | +38.9% | 7,1 M € | -3.7% | 7,3 M € | +14.6% | 6,4 M € | -11.4% | 7,2 M € |
| Cash | 645,1 k € | -62.6% | 1,7 M € | +39.3% | 1,2 M € | -37.8% | 2 M € | +140% | 828,5 k € | +1000% | 75,3 k € | +585% | 11 k € | -94.1% | 186,7 k € | +2276% | 7,9 k € | -95.1% | 159,7 k € | -74.4% | 623,1 k € | +8.7% | 573,2 k € | +227% | 175,5 k € |
| Debts | 18,5 M € | +10.8% | 16,7 M € | -4.6% | 17,5 M € | +31.3% | 13,4 M € | -8.9% | 14,7 M € | -10.9% | 16,5 M € | +38.4% | 11,9 M € | +32.5% | 9 M € | +5.6% | 8,5 M € | +25.7% | 6,8 M € | -3.3% | 7 M € | +14.3% | 6,1 M € | -10.2% | 6,8 M € |
| Other | |||||||||||||||||||||||||
| Workforce | 29,0 ETP | +26.1% | 23,0 ETP | +22.3% | 18,8 ETP | +8.7% | 17,3 ETP | +14.6% | 15,1 ETP | +30.2% | 11,6 ETP | +31.8% | 8,8 ETP | -1.1% | 8,9 ETP | +2.3% | 8,7 ETP | +24.3% | 7,0 ETP | +16.7% | 6,0 ETP | +25.0% | 4,8 ETP | +14.3% | 4,2 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2024 · 1 active · 31 ended
Active mandates
Ended mandates
Other companies at this address
Financials
Full financial information
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/06/2025 | 31/07/2024 | 11/07/2023 | 22/06/2022 | 24/06/2021 | 16/07/2020 |
| General meeting | 14/06/2025 | 28/06/2024 | 30/06/2023 | 19/05/2022 | 10/06/2021 | 07/07/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
26 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2024 | 14/06/2025 | 23/06/2025 | Dutch | |
| Full model | 31/12/2023 | 28/06/2024 | 31/07/2024 | Dutch | |
| Full model | 31/12/2022 | 30/06/2023 | 11/07/2023 | Dutch | |
| Full model | 31/12/2021 | 19/05/2022 | 22/06/2022 | Dutch | |
| Full model | 31/12/2020 | 10/06/2021 | 24/06/2021 | Dutch | |
| Full model | 31/12/2019 | 07/07/2020 | 16/07/2020 | Dutch | |
| Full model | 31/12/2018 | 26/06/2019 | 11/07/2019 | Dutch | |
| Full model | 31/12/2017 | 29/06/2018 | 19/07/2018 | Dutch | |
| Full model | 31/12/2016 | 05/10/2017 | 09/10/2017 | Dutch | |
| Full model | 31/12/2015 | 30/06/2016 | 04/07/2016 | Dutch | |
| Full model | 31/12/2014 | 31/08/2015 | 14/09/2015 | Dutch | |
| m122-f-p | 31/12/2014 | 31/08/2015 | 14/09/2015 | Dutch | |
| Full model | 31/12/2013 | 30/06/2014 | 07/08/2014 | Dutch | |
| m122-f-p | 31/12/2013 | 01/01/9999 | 07/08/2014 | Dutch | |
| Full model | 31/12/2012 | 24/10/2013 | 13/12/2013 | Dutch | |
| m122-f-p | 31/12/2012 | 25/10/2013 | 18/12/2013 | Dutch | |
| Full model | 31/12/2011 | 26/09/2012 | 27/09/2012 | Dutch | |
| m122-f-p | 31/12/2011 | 31/08/2012 | 31/08/2012 | Dutch | |
| Full model | 31/12/2010 | 28/07/2011 | 07/09/2011 | Dutch | |
| m122-f-p | 31/12/2010 | 28/07/2011 | 23/12/2011 | Dutch | |
| Full model | 31/12/2009 | 14/07/2010 | 29/10/2010 | Dutch | |
| m122-f-p | 31/12/2009 | 20/05/2010 | 21/12/2010 | Dutch | |
| Full model | 31/12/2008 | 30/06/2009 | 10/08/2009 | Dutch | |
| Full model | 31/12/2007 | 03/09/2008 | 06/10/2008 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2024 · 1 active · 31 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Other12/03/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates21/06/2023ONTSLAGEN - BENOEMINGEN
- Mandates27/07/2020ONTSLAGEN - BENOEMINGEN
- Mandates18/11/2019ONTSLAGEN - BENOEMINGEN
- Mandates17/12/2018DEMISSIONS, NOMINATIONS
- Mandates01/08/2018ONTSLAGEN - BENOEMINGEN
- Mandates11/04/2018ONTSLAGEN - BENOEMINGEN
- Mandates26/01/2018ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024178,9 k €↑
- 2023Annual accounts 202341,8 k €↓
- 2022Annual accounts 2022147,3 k €↓
- 2021Annual accounts 2021485,5 k €↑
- 2020Annual accounts 2020327,2 k €↓
- 2019Annual accounts 2019674 k €↓
- 2018Annual accounts 2018935,5 k €↑
- 2017Annual accounts 2017275,4 k €↓
- 2017Name changePharma Base
- 2010Annual accounts 2010728,4 k €↑
- 2009Annual accounts 200920,8 k €↑
- 2008Annual accounts 2008-6,9 k €↑
- 2007Annual accounts 2007-102 k €↓
- 2007Name changePATRONA PHARMA
- 2006Annual accounts 2006-61,9 k €
- 2006Name changePATRONA PHARMA GROUP INTERNATIONAL
- 10/10/1990IncorporationPublic limited company